×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TTOO – t2 biosystems, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TTOO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
02:34 am
ttoo
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
Low
Report
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... [Yahoo! Finance]
11/14
04:17 pm
ttoo
T2 Biosystems Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
T2 Biosystems Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
11/14
04:05 pm
ttoo
T2 Biosystems Announces Third Quarter 2024 Financial Results
Medium
Report
T2 Biosystems Announces Third Quarter 2024 Financial Results
11/5
08:00 am
ttoo
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
Medium
Report
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
10/10
08:29 pm
ttoo
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript [Seeking Alpha]
Low
Report
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript [Seeking Alpha]
10/8
04:14 pm
ttoo
T2 Biosystems to Host Business Update Call on October 10, 2024 [Yahoo! Finance]
Medium
Report
T2 Biosystems to Host Business Update Call on October 10, 2024 [Yahoo! Finance]
10/8
04:05 pm
ttoo
T2 Biosystems to Host Business Update Call on October 10, 2024
Low
Report
T2 Biosystems to Host Business Update Call on October 10, 2024
10/8
09:00 am
ttoo
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
Medium
Report
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/15
09:54 am
ttoo
Form 8-K T2 Biosystems, Inc. For: Nov 14
Medium
Report
Form 8-K T2 Biosystems, Inc. For: Nov 14
11/14
03:50 pm
ttoo
Form 10-Q T2 Biosystems, Inc. For: Sep 30
Low
Report
Form 10-Q T2 Biosystems, Inc. For: Sep 30
11/14
03:39 pm
ttoo
Form SC 13G T2 Biosystems, Inc. Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G T2 Biosystems, Inc. Filed by: ARMISTICE CAPITAL, LLC
11/8
05:01 pm
ttoo
Form PRE 14A T2 Biosystems, Inc. For: Dec 30
Low
Report
Form PRE 14A T2 Biosystems, Inc. For: Dec 30
11/8
09:30 am
ttoo
Form 8-K T2 Biosystems, Inc. For: Nov 07
High
Report
Form 8-K T2 Biosystems, Inc. For: Nov 07
11/6
09:03 pm
ttoo
Form SC 13G T2 Biosystems, Inc. Filed by: JSAF Holdings, LLC
Medium
Report
Form SC 13G T2 Biosystems, Inc. Filed by: JSAF Holdings, LLC
11/6
09:02 pm
ttoo
Form SC 13G T2 Biosystems, Inc. Filed by: Safier Jacob
Medium
Report
Form SC 13G T2 Biosystems, Inc. Filed by: Safier Jacob
10/16
05:00 pm
ttoo
Form 8-K T2 Biosystems, Inc. For: Oct 10
Medium
Report
Form 8-K T2 Biosystems, Inc. For: Oct 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/10
Form 8-K T2 Biosystems, Inc. For: Sep 06
82.5%
3/18 Form 4 T2 Biosystems, Inc. For: Mar 14 Filed by: Pare Anthony 34.3%
2/27 Form 8-K T2 Biosystems, Inc. For: Feb 24 27.1%
9/3 IBN, I among premarket losers [Seeking Alpha] 24.2%
3/24 T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results 20.7%
4/15 T2 Biosystems Reports Granting of Inducement Award 20.1%
9/11 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.50 price target on the stock, up previously from $2.50. 18.5%
11/15 T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum 16.6%
3/16 Form 10-K T2 Biosystems, Inc. For: Dec 31 15.7%
8/6 T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS 13.9%
3/18 Form 4 T2 Biosystems, Inc. For: Mar 14 Filed by: Pare Anthony 34.3%
2/27 Form 8-K T2 Biosystems, Inc. For: Feb 24 27.1%
9/3 IBN, I among premarket losers [Seeking Alpha] 24.2%
3/24 T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results 20.7%
4/15 T2 Biosystems Reports Granting of Inducement Award 20.1%
9/11 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.50 price target on the stock, up previously from $2.50. 18.5%
11/15 T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum 16.6%
3/16 Form 10-K T2 Biosystems, Inc. For: Dec 31 15.7%
8/6 T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS 13.9%
TOP News Decliners
7/30
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
-58.7%
11/12 T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update -29.1%
3/25 The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down [Yahoo! Finance News] -25.5%
2/24 Q4/2019 12/31/2019 EPS -0.300 ZacksConsensus -0.270 ActVsEst (0.030) - Miss -21.8%
12/13 T2 Biosystems Reports Granting of Inducement Awards -16.5%
11/13 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.00 price target on the stock. -15.5%
1/31 T2 Biosystems Inc (NASDAQ: TTOO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.2%
2/25 Form 4 T2 Biosystems, Inc. For: Feb 21 Filed by: Lowery Thomas J. -14.9%
11/14 C. Auris, The Deadly Fungus CDC Says It’s “Still Trying To Figure Out?” [Forbes] -13.2%
3/10 Form 8-K T2 Biosystems, Inc. For: Mar 09 -11.5%
11/12 T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update -29.1%
3/25 The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down [Yahoo! Finance News] -25.5%
2/24 Q4/2019 12/31/2019 EPS -0.300 ZacksConsensus -0.270 ActVsEst (0.030) - Miss -21.8%
12/13 T2 Biosystems Reports Granting of Inducement Awards -16.5%
11/13 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.00 price target on the stock. -15.5%
1/31 T2 Biosystems Inc (NASDAQ: TTOO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.2%
2/25 Form 4 T2 Biosystems, Inc. For: Feb 21 Filed by: Lowery Thomas J. -14.9%
11/14 C. Auris, The Deadly Fungus CDC Says It’s “Still Trying To Figure Out?” [Forbes] -13.2%
3/10 Form 8-K T2 Biosystems, Inc. For: Mar 09 -11.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: